Image credit: Jack Sprat

The New Congress Takes Its First Crack at Cannabis Reform

The industry’s lack of access to banks, the subject of a congressional subcommittee hearing today, is a major problem for the booming industry and consumers alike.

Congress
New York

Leading New York Lawmaker “Optimistic” About Cannabis Legalization’s Chances in 2020

New York Senator Liz Krueger, speaking at a cannabis event on Tuesday evening, also shared where the state’s legalization effort this year went wrong.

Newsletter

More FDA and FTC warnings to CBD sellers • Horizons ETFs: cannabis has lost its “buzz” • & more…

An excerpt from the October 23 edition of the Cannabis Wire Daily newsletter.

Lobbying

The Incredibly Large Lobbying Footprint of Greenwich Biosciences

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states.